This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, M.
Right arrow Articles by Katz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, M.
Right arrow Articles by Katz, J.

 Previous Article  |  Next Article 

Infection and Immunity, May 2003, p. 2498-2507, Vol. 71, No. 5
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.5.2498-2507.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A

Michael Martin,1 Suzanne M. Michalek,1,2 and Jannet Katz2*

Department of Microbiology,1 Department of Oral Biology, University of Alabama at Birmingham, Birmingham, Alabama 352942

Received 18 September 2002/ Returned for modification 6 January 2003/ Accepted 12 February 2003

Monophosphoryl lipid A (MPL) is a nontoxic derivative of lipopolysaccharide (LPS) that exhibits adjuvant properties similar to those of the parent LPS molecule. However, the mechanism by which MPL initiates its immunostimulatory properties remains unclear. Due to the involvement of Toll-like receptors in recognizing and transducing intracellular signals in response to LPS, the aim of the present study was to determine the ability of MPL to utilize the Toll-like receptor 2 (TLR2) and TLR4. We provide evidence that MPL differentially utilizes TLR2 and TLR4 for the induction of tumor necrosis factor alpha, interleukin 10 (IL-10), and IL-12 by purified human monocytes as well as by human peripheral blood mononuclear cells. Assessment of NF-{kappa}B activity demonstrated that MPL utilized TLR2 and especially TLR4 for the activation of NF-{kappa}B p65 by human monocytes. In addition, stimulation of human monocytes by MPL led to an up-regulation of the costimulatory molecules CD80 and CD86, an effect that could be reduced by pretreatment of cells with a monoclonal antibody to TLR2 or TLR4. Analysis of MPL-induced activation of the extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein (MAP) kinases revealed that MPL utilized both TLR2 and TLR4 for the phosphorylation of ERK1/2, while TLR4 was the predominant receptor involved in the ability of MPL to phosphorylate p38. Moreover, using selective inhibitors for MAP kinase kinase (PD98059) and p38 (SB203580), we show that ERK1/2 exhibited differential effects on production of TNF-{alpha} and IL-12 p40 by human monocytes, whereas MPL-induced activation of p38 appeared to be predominantly involved in production of IL-10 and IL-12 p40 by MPL-stimulated monocytes. Taken together, these findings aid in understanding the cellular mechanisms by which MPL induces host cell activation and subsequent adjuvant properties.

* Corresponding author. Mailing address: Departments of Microbiology and Oral Biology, University of Alabama at Birmingham, 845 19th St. South, BBRB 713/5, Birmingham, AL 35294-2170. Phone: (205) 934-2878. Fax: (205) 934-1426. E-mail: jenny_katz{at}micro.microbio.uab.edu.

Editor: J. D. Clements

Infection and Immunity, May 2003, p. 2498-2507, Vol. 71, No. 5
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.5.2498-2507.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Zhang, H., Hong, H., Li, D., Ma, S., Di, Y., Stoten, A., Haig, N., Di Gleria, K., Yu, Z., Xu, X.-N., McMichael, A., Jiang, S. (2009). Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells. J. Biol. Chem. 284: 9184-9191 [Abstract] [Full Text]  
  • Chiavolini, D., Weir, S., Murphy, J. R., Wetzler, L. M. (2008). Neisseria meningitidis PorB, a Toll-Like Receptor 2 Ligand, Improves the Capacity of Francisella tularensis Lipopolysaccharide To Protect Mice against Experimental Tularemia. CVI 15: 1322-1329 [Abstract] [Full Text]  
  • Airhart, C. L., Rohde, H. N., Bohach, G. A., Hovde, C. J., Deobald, C. F., Lee, S. S., Minnich, S. A. (2008). Induction of innate immunity by lipid A mimetics increases survival from pneumonic plague. Microbiology 154: 2131-2138 [Abstract] [Full Text]  
  • Andreani, V., Gatti, G., Simonella, L., Rivero, V., Maccioni, M. (2007). Activation of Toll-like Receptor 4 on Tumor Cells In vitro Inhibits Subsequent Tumor Growth In vivo. Cancer Res. 67: 10519-10527 [Abstract] [Full Text]  
  • Burke, J. M., Ganley-Leal, L. M., Khatri, A., Wetzler, L. M. (2007). Neisseria meningitidis PorB, a TLR2 Ligand, Induces an Antigen-Specific Eosinophil Recall Response: Potential Adjuvant for Helminth Vaccines?. J. Immunol. 179: 3222-3230 [Abstract] [Full Text]  
  • Geurtsen, J., Banus, H. A., Gremmer, E. R., Ferguson, H., de la Fonteyne-Blankestijn, L. J. J., Vermeulen, J. P., Dormans, J. A. M. A., Tommassen, J., van der Ley, P., Mooi, F. R., Vandebriel, R. J. (2007). Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice. CVI 14: 821-829 [Abstract] [Full Text]  
  • Luxameechanporn, T., Kirtsreesakul, V., Klemens, J., Khoury, P., Thompson, K., Naclerio, R. M. (2005). Evaluation of Importance of Toll-like Receptor 4 in Acute Streptococcus pneumoniae Sinusitis in Mice. Arch Otolaryngol Head Neck Surg 131: 1001-1006 [Abstract] [Full Text]  
  • Gurnani, K., Kennedy, J., Sad, S., Sprott, G. D., Krishnan, L. (2004). Phosphatidylserine Receptor-Mediated Recognition of Archaeosome Adjuvant Promotes Endocytosis and MHC Class I Cross-Presentation of the Entrapped Antigen by Phagosome-to-Cytosol Transport and Classical Processing. J. Immunol. 173: 566-578 [Abstract] [Full Text]  
  • Skeiky, Y. A. W., Alderson, M. R., Ovendale, P. J., Guderian, J. A., Brandt, L., Dillon, D. C., Campos-Neto, A., Lobet, Y., Dalemans, W., Orme, I. M., Reed, S. G. (2004). Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein. J. Immunol. 172: 7618-7628 [Abstract] [Full Text]  
  • Stover, A. G., Da Silva Correia, J., Evans, J. T., Cluff, C. W., Elliott, M. W., Jeffery, E. W., Johnson, D. A., Lacy, M. J., Baldridge, J. R., Probst, P., Ulevitch, R. J., Persing, D. H., Hershberg, R. M. (2004). Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists. J. Biol. Chem. 279: 4440-4449 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»